Can lymphocyte counts be low in viral infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Lymphocytes Be Low in Viral Infections?

Yes, lymphocyte counts can be low in viral infections, and lymphopenia is a well-recognized hematologic finding in many viral illnesses, including COVID-19, RSV, and other respiratory viruses.

Lymphopenia as a Common Viral Infection Finding

  • In COVID-19 infections, lymphopenia is one of the most prominent laboratory abnormalities, with the early stage of disease characterized by decreased total leukocyte counts or normal counts with decreased lymphocyte counts 1.

  • Specific attention should be paid when the absolute lymphocyte value falls below 0.8 × 10⁹/L, as this threshold warrants rechecking blood routine changes after 3 days 1.

  • Lymphopenia occurs in the majority of severe COVID-19 patients and is strongly associated with mortality rate 2. The presence of lymphopenia (less than 1.5 × 10⁹/L) is associated with nearly threefold increased risk of severe COVID-19 3.

Mechanisms and Clinical Significance

  • Both viral-mediated and immune-mediated mechanisms contribute to lymphopenia through influencing lymphocyte production, survival, or tissue redistribution 2.

  • Lymphopenia can cause general immunosuppression and promote cytokine storm, both playing important roles in viral persistence, viral replication, multi-organ failure, and death 2.

  • Circulating CD4+ cells, CD8+ cells, regulatory T cells, and natural killer cells may all be reduced, with greater reductions observed in critically ill patients 4.

Lymphopenia in Immunocompromised Patients

  • In immunocompromised patients with RSV infection, profound lymphopenia (<100 cells/mm³) is associated with progression from upper to lower respiratory tract disease 1.

  • An absolute lymphocyte count of 100 cells/mm³ or less at the time of RSV upper tract infection predicts progression to lower respiratory tract disease, while progression did not occur in patients with lymphocyte counts greater than 1000 cells/mm³ 1.

  • In HIV-infected patients, CD4+ lymphocyte counts below 200 cells/μL indicate increased susceptibility to opportunistic infections, and these patients should be suspected of having Pneumocystis pneumonia, tuberculosis, and other opportunistic infections when presenting with unexplained cough 1.

Prognostic Value

  • Delta lymphocytes at 24 hours (the difference between lymphocyte values at H24 and upon admission) is a significant biochemical factor associated with mortality in COVID-19 patients, with a delta <135 cells/mm³ being one of the most significant predictors (OR: 2.23) 5.

  • The most accurate threshold for delta lymphocytes H24 is 75 to predict severity and 135 for mortality in SARS-CoV-2 infection 5.

Common Pitfalls

  • Do not assume that normal or elevated white blood cell counts exclude significant viral infection, as the total WBC may be normal while lymphocyte counts are specifically decreased 1.

  • Avoid relying solely on a single lymphocyte measurement—serial monitoring is essential, particularly in the first 3 days of illness, as dynamic changes provide more prognostic information than static values 1, 5.

  • Do not overlook lymphopenia in the context of other viral infections beyond COVID-19, as similar alterations occur in various viral infections including RSV, influenza, and other respiratory viruses 4, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.